Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Prognostic value of reported chest pain for cardiovascular risk stratification in primary care.

Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM; DETECT Study Group.

Eur J Prev Cardiol. 2014 Jun;21(6):727-38. doi: 10.1177/2047487312452503. Epub 2012 Jun 27.

PMID:
22739685
2.

Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention.

Leistner DM, Klotsche J, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM; DETECT Study Group.

Clin Chem. 2012 Jan;58(1):200-8. doi: 10.1373/clinchem.2011.174292. Epub 2011 Dec 7.

3.

Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency.

Schneider HJ, Klotsche J, Wittchen HU, Stalla GK, Schopohl J, Kann PH, Kreitschmann-Andermahr I, Wallaschofski H; German KIMS board and of the DETECT study.

Clin Endocrinol (Oxf). 2011 Dec;75(6):825-30. doi: 10.1111/j.1365-2265.2011.04137.x.

PMID:
21658091
4.

Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information?

Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM; DETECT-Study Group.

Eur J Prev Cardiol. 2012 Apr;19(2):275-84. doi: 10.1177/1741826710394304. Epub 2011 Feb 18.

PMID:
21450610
5.

Random drug tests at work: the probability of identifying frequent and infrequent users of illicit drugs.

DuPont RL, Griffin DW, Siskin BR, Shiraki S, Katze E.

J Addict Dis. 1995;14(3):1-17.

PMID:
8555274

Supplemental Content

Loading ...
Write to the Help Desk